• Medientyp: E-Artikel
  • Titel: Triggering of B7h by the ICOS Modulates Maturation and Migration of Monocyte-Derived Dendritic Cells
  • Beteiligte: Occhipinti, Sergio; Dianzani, Chiara; Chiocchetti, Annalisa; Boggio, Elena; Clemente, Nausicaa; Gigliotti, Casimiro Luca; Soluri, Maria Felicia; Minelli, Rosalba; Fantozzi, Roberto; Yagi, Jungi; Rojo, Josè Maria; Sblattero, Daniele; Giovarelli, Mirella; Dianzani, Umberto
  • Erschienen: The American Association of Immunologists, 2013
  • Erschienen in: The Journal of Immunology
  • Sprache: Englisch
  • DOI: 10.4049/jimmunol.1201816
  • ISSN: 0022-1767; 1550-6606
  • Schlagwörter: Immunology ; Immunology and Allergy
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:title>Abstract</jats:title> <jats:p>B7h, expressed by several cell types, binds ICOS expressed by activated T cells. We have previously shown that B7h triggering by ICOS-Fc inhibits human endothelial cell adhesiveness. This work investigated the effect of ICOS-Fc on human monocyte-derived dendritic cells (DCs). We found that DCs matured with LPS in the presence of ICOS-Fc (mDCsICOS) produced greater amounts of IL-23 and IL-10, and promoted a higher secretion of IL-17A and IL-17F in MLCs than did those DCs matured with LPS alone (mDCs). Moreover, mDCsICOS pulsed with the keyhole limpet hemocyanin Ag during the maturation phase were better stimulators of Ag-specific MHC class I–, but not class II–restricted T cells than mDCs. This was probably due to promotion of cross-presentation because it was not detected when the Flu-MA58–66 Ag was directly loaded on already matured DCs and mDCsICOS. Finally, ICOS-Fc inhibited the adhesion of both immature DCs and mDCs to vascular and lymphoid endothelial cells, their migratory activity, and the expression of the Rac-1 activator β-Pix involved in cell motility. These data suggest that B7h stimulation modulates DC function with effects on their maturation and recruitment into tissues. This opens a novel view on the use of interactors of the ICOS:B7h system as immunomodulatory drugs.</jats:p>
  • Zugangsstatus: Freier Zugang